本书以「SDE 慢性病医学」为根基，对慢性病作一次根本性的重思。它不是又一套控糖策略，而是挑战「糖尿病是一种由数字指标定义与统辖的终身病」这一主流假设。常规糖尿病照护依赖「指标治理」——血糖阈值、糖化目标、药物升级；这些指标虽能降低短期风险，却常常无法恢复长期稳定所需的底层生理能力。本书主张：糖尿病首要不是一种代谢失调，而是一种「通路失调」——葡萄糖出口路径与时间结构化清除的失败。
葡萄糖真正的危险不在它的「存在」，而在它「在血流里滞留太久」——「太多、太久」——逐渐损伤血管、神经与器官。扎根于把健康与疾病定义为「主体—互动—客体系统之涌现态」的 SIO 本体论，以及通过显露（S）、差异序列动力（D）、纠缠网络（E）来分析生物系统的 SDE 理论，本书把糖尿病重构为一个「结构性坍塌」而非「数值偏离」的问题：肌肉摄取、肝的储存与释放、细胞的基线利用、血管的时间动力（峰宽与延迟的尾巴）、以及清除能力，成为解释与干预的中心对象。
本书批判性地审视以指标为中心的医学，揭示长期的数值控制如何制造出「虚假的稳定」，而生理能力仍在持续侵蚀；它也对主流降糖药作一次结构性、非意识形态的分析，厘清它们的保护作用、局限，以及为何药物无法替代生物学的重建。最重要的是，本书引入「通路工程」——一种可验证的路径，聚焦于重建出口路径、恢复时间结构、找回系统能力；在这个框架里，停药不是意志力的行为，而是「结构修复完成」后自然的结果。写给临床医生、研究者与认真的读者，本书为以指标驱动的医学提供了一个融贯的替代方案——一个以「恢复的生物能力与长期稳定」而非仅以数字来定义康复的方案。
Reversing Diabetes presents a fundamental rethinking of chronic disease grounded in SDE Chronic Disease Medicine, a theory derived from the broader SIO-SDE philosophical framework. Rather than offering another strategy for glucose control, this book challenges the dominant assumption that diabetes is a lifelong condition defined and governed by numerical indicators. Conventional diabetes care relies on metric governance-blood glucose thresholds, HbA1c targets, and medication escalation. While such metrics reduce short-term risk, they often fail to restore the underlying physiological capacity required for long-term stability.
This book argues that diabetes is not primarily a metabolic disorder, but a pathway disorder: a failure of glucose exit routes and time-structured clearance. The true danger of glucose lies not in its presence, but in its prolonged retention in the bloodstream-"too much for too long"-which gradually damages vessels, nerves, and organs. Grounded in SIO Ontology, which defines health and disease as emergent states of Subject-Interaction-Object systems, and SDE Theory, which analyzes biological systems through Structure (S), Difference-sequence dynamics (D), and Entanglement networks (E), the book reframes diabetes as a problem of structural collapse rather than numerical deviation. Muscular uptake, hepatic storage and release, baseline cellular utilization, vascular time dynamics (peak width and delayed tail), and clearance capacity become the central objects of explanation and intervention.
The book critically examines indicator-centered medicine, revealing how long-term metric control can produce "false stability" while physiological capability continues to erode. It also offers a structural, non-ideological analysis of mainstream glucose-lowering drugs, clarifying their protective roles, limitations, and why medication cannot substitute for biological reconstruction. Most importantly, Reversing Diabetes introduces pathway engineering-a verifiable approach focused on rebuilding exit routes, restoring time structure, and recovering systemic capacity. Within this framework, medication withdrawal is not an act of willpower, but the natural outcome of completed structural restoration.
Written for clinicians, researchers, and serious readers, this book offers a coherent alternative to metric-driven medicine-one that defines recovery by restored biological capability and long-term stability, rather than numbers alone.